Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): Possible involvement of calcium and nitric oxide

Behavioural Pharmacology

Volumn 12, Issue 3, 2001, Pages 209-216

  Naidu, P S ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Calcium; Glutamate; Neuroleptics; Nitric oxide; NMDA; Rat; Tardive dyskinesia; Vacuous chewing movements

Indexed keywords

ARGININE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DIZOCILPINE; DOPAMINE 2 RECEPTOR; FELODIPINE; GLUTAMIC ACID; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NEUROLEPTIC AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RECEPTOR BLOCKING; DOSE RESPONSE; EXCITATION; HUMAN; LONG TERM CARE; MALE; MASTICATION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; RAT; TARDIVE DYSKINESIA;

EID: 0034943420     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200105000-00006     Document Type: Article

References (41)

1. GM1 ganglioside attenuates the development of vacuous chewing movements induced by long-term haloperidol treatment of rats
2. 1 dopamine receptors through a cAMP/protein kinase A-dependent mechanism
3. Biogenicamines facilitate N-methyl-DL-aspartate responses in the guinea-pig neocortex in vitro
4. Effects of glutamate antagonists on nigral dopamine release in the reserpine treated rat
5. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications schizophrenia and Parkinson's disease
6. Dopaminergic modulation of NMDA-induced whole-cell currents in neostriatal neurons in slice: Contribution of calcium conductance
7. Effect of MK-801 on the prevention and treatment of vacuous chewing in rats
8. On the mode of action of apomorphine
9. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
10. Excitotoxic mechanisms may be involved in the pathophysiology of tardive dyskinesia
11. Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs
12. Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurons
13. Glutamate, nitric oxide and cell-cell signaling in the nervous system
14. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
15. Ultrastructural immunocytochemical localization of the N-methyl-D-aspartate receptor and tyrosine hydroxylase in the shell of the rat nucleus accumbens
16. Ultrastructural localization and comparative distribution of nitric oxide synthase and N-methyl-D-aspartate receptors in the shell of the rat nucleus accumbens
17. Emergence of oral and locomotor activity in chronic-haloperidol-treated rats following cotrical N-methyl-D-aspartate stimulation
18. An animal model for coexisting tardive dyskinesia and tardive parkinsonism: A glutamate hypothesis for tardive dyskinesia
19. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration
20. Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-arginine-methyl ester
21. Memantine inhibits the development of haloperidol-induced persistent oral movements
22. 2 receptor antagonists on oral activity in rats
23. Dopamine modulation of NMDA-induced calcium transients in fetal neocortical cultures and dissociated neostriatal neurons
24. Antiglutamatergic effects of clozapine
25. Antipsychotic drug effects on glutamatergic activity
26. Chronic antipyschotic treatment alters glycine-stimulated NMDA receptor binding in rat brain
27. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kinic acids
28. Differential regulation of hippocampal AMPA and kinate receptor subunit expression by haloperidol and clozapine
29. Haloperidol-induced morphological changes in striatum are associated with glutamate synapse
30. Extracellular concentrations of aspartate and glutamate in rat neostriatum following chemical stimulation of frontal cortex
31. Delayed production of nitric oxide contributes to NMDA-mediated neuronal damage
32. 1 stimulation
33. Rolipram, a selective c-AMP phosphodiesterase inhibitor supresses oro-facial dyskinetic movements in rats
34. Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats
35. Chronic haloperidol potentiates stimulated glutamate release in caudate putamen, but not pre-frontal cortex
36. Duration-dependent increase in striatal glutamate following prolonged fluphenazine administration in rats
37. 1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
38. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia
39. Chronic haloperidol alters substantia nigra GABA and extracellular glutamate in the striatum
40. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations
41. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis